Eur Rev Med Pharmacol Sci 2021; 25 (4): 1767-1767

DOI: 10.26355/eurrev_202102_25056

Author Correction: LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma

L. Peng, Y.-H. Liu, S. Nie, M. Gao

Department of Pediatrics, The First Hospital of Jilin University, Changchun City, Jilin Province, China


Correction to: European Review for Medical and Pharmacological Sciences 2020; 24 (16): 8367-8376–DOI: 10.26355/eurrev_202008_22633–PMID: 32894543, published online 31 August, 2020.

The authors state that “the segment of Figure 2C (si-RNA-NC) was used twice due to a careless mistake during the preparation of Figure 2”.

There are amendements to this paper. The Publisher apologizes for any inconvenience this may cause.

LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma

Free PDF Download

To cite this article

L. Peng, Y.-H. Liu, S. Nie, M. Gao
Author Correction: LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 4
Pages: 1767-1767
DOI: 10.26355/eurrev_202102_25056